|

Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin

RECRUITINGPhase 2Sponsored by National Institute on Aging (NIA)
Actively Recruiting
PhasePhase 2
SponsorNational Institute on Aging (NIA)
Started2026-11-04
Est. completion2030-12-31
Eligibility
Age65 Years – 120 Years
Healthy vol.Accepted
Locations1 site

Summary

Background: Normal aging, as well as dementias such as Alzheimer s disease, can cause changes in the brain that affect memory, attention, and thinking. Researchers want to know if regular mental tasks (cognitive training) can improve brain function in older adults. They also want to know if psilocybin, a compound found in certain mushrooms, can further support improved brain function. Objective: To learn how regular cognitive training, with or without psilocybin, can improve brain health in older adults. Eligibility: People aged 65 years and older with mild cognitive impairment or early-stage Alzheimer s disease. Healthy older adults with normal cognition are also needed. Design: Participants will be screened. They will have a test of their heart function and an imaging scan. They will have mental health screening and tests of their thinking and memory. They will practice brain-training tasks on a tablet. Participants will be divided into 2 groups: 1 will have cognitive training plus psilocybin; 1 will have cognitive training only. Those having cognitive training only will have 5 or 6 clinic visits. They will take the tablet home to practice brain training daily. They will wear a device to measure brain waves as they sleep; they may have 1 overnight stay in the clinic, or they may wear the device at home. Imaging scans and other tests will be repeated at each visit. Those taking psilocybin will have up to 9 clinic visits. In addition to the visits for cognitive training, they will take 1 psilocybin capsule by mouth 2 weeks apart (the second dose is optional). They will remain in the clinic for 24 hours after each dose.

Eligibility

Age: 65 Years – 120 YearsHealthy volunteers accepted
* Pending Web Eligibility

Conditions1

Alzheimer's Disease

Interventions1

Locations1 site

National Institute of Aging, Clinical Research Unit
Dimitrios Kapogiannis, M.D.667-391-0063kapogiannisd@mail.nih.gov

Find trials near these locations

Related trials

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.